These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 26314275

  • 1. Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysis.
    De Cruz P, Kamm MA, Hamilton AL, Ritchie KJ, Krejany EO, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Jakobovits S, Florin TH, Gibson PR, Debinski H, Gearry RB, Macrae FA, Leong RW, Kronborg I, Radford-Smith G, Selby W, Johnston MJ, Woods R, Elliott PR, Bell SJ, Brown SJ, Connell WR, Desmond PV.
    Aliment Pharmacol Ther; 2015 Oct; 42(7):867-79. PubMed ID: 26314275
    [Abstract] [Full Text] [Related]

  • 2. Crohn's disease management after intestinal resection: a randomised trial.
    De Cruz P, Kamm MA, Hamilton AL, Ritchie KJ, Krejany EO, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Gibson PR, Sparrow M, Leong RW, Florin TH, Gearry RB, Radford-Smith G, Macrae FA, Debinski H, Selby W, Kronborg I, Johnston MJ, Woods R, Elliott PR, Bell SJ, Brown SJ, Connell WR, Desmond PV.
    Lancet; 2015 Apr 11; 385(9976):1406-17. PubMed ID: 25542620
    [Abstract] [Full Text] [Related]

  • 3. Endoscopic Prediction of Crohn's Disease Postoperative Recurrence.
    De Cruz P, Hamilton AL, Burrell KJ, Gorelik A, Liew D, Kamm MA.
    Inflamm Bowel Dis; 2022 May 04; 28(5):680-688. PubMed ID: 34231852
    [Abstract] [Full Text] [Related]

  • 4. Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients.
    Aguas M, Bastida G, Cerrillo E, Beltrán B, Iborra M, Sánchez-Montes C, Muñoz F, Barrio J, Riestra S, Nos P.
    World J Gastroenterol; 2012 Aug 28; 18(32):4391-8. PubMed ID: 22969204
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study.
    González-Lama Y, Suárez C, González-Partida I, Calvo M, Matallana V, de la Revilla J, Magaz M, Bernardo C, Agudo B, Ibarrola P, Relea L, Arévalo J, Vera MI, Abreu L.
    J Crohns Colitis; 2016 Jan 28; 10(1):55-60. PubMed ID: 26520164
    [Abstract] [Full Text] [Related]

  • 7. Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's Disease.
    Vasudevan A, Raghunath A, Anthony S, Scanlon C, Sparrow MP, Gibson PR, van Langenberg DR.
    Dig Dis Sci; 2019 Jun 28; 64(6):1622-1631. PubMed ID: 30560332
    [Abstract] [Full Text] [Related]

  • 8. Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis.
    Cañete F, Mañosa M, Pérez-Martínez I, Barreiro-de Acosta M, González-Sueyro RC, Nos P, Iglesias-Flores E, Gutiérrez A, Bujanda L, Gordillo J, Ríos León R, Casanova MJ, Villoria A, Rodríguez-Lago I, López Serrano P, García-Herola A, Ramírez-de la Piscina P, Navarro-Llavat M, Taxonera C, Barrio J, Ramos L, Navarro P, Benítez-Leiva O, Calafat M, Domènech E, INFLIRECU study.
    Clin Transl Gastroenterol; 2020 Aug 28; 11(8):e00218. PubMed ID: 32955190
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting.
    Allocca M, Landi R, Bonovas S, Fiorino G, Papa A, Spinelli A, Furfaro F, Peyrin-Biroulet L, Armuzzi A, Danese S.
    Digestion; 2017 Aug 28; 96(3):166-172. PubMed ID: 28903094
    [Abstract] [Full Text] [Related]

  • 12. Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study.
    Papamichael K, Archavlis E, Lariou C, Mantzaris GJ.
    J Crohns Colitis; 2012 Oct 28; 6(9):924-31. PubMed ID: 22424843
    [Abstract] [Full Text] [Related]

  • 13. Direct retrospective comparison of adalimumab and infliximab in preventing early postoperative endoscopic recurrence after ileocaecal resection for crohn's disease: results from the MULTIPER database.
    Kotze PG, Yamamoto T, Danese S, Suzuki Y, Teixeira FV, de Albuquerque IC, Saad-Hossne R, de Barcelos IF, da Silva RN, da Silva Kotze LM, Olandoski M, Sacchi M, Yamada A, Takeuchi K, Spinelli A.
    J Crohns Colitis; 2015 Jul 28; 9(7):541-7. PubMed ID: 25820017
    [Abstract] [Full Text] [Related]

  • 14. Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised Trial.
    López-Sanromán A, Vera-Mendoza I, Domènech E, Taxonera C, Vega Ruiz V, Marín-Jiménez I, Guardiola J, Castro L, Esteve M, Iglesias E, Ceballos D, Martínez-Montiel P, Gisbert JP, Mínguez M, Echarri A, Calvet X, Barrio J, Hinojosa J, Martín-Arranz MD, Márquez-Mosquera L, Bermejo F, Rimola J, Pons V, Nos P, Spanish GETECCU group [APPRECIA study].
    J Crohns Colitis; 2017 Oct 27; 11(11):1293-1301. PubMed ID: 28402454
    [Abstract] [Full Text] [Related]

  • 15. Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn's Disease.
    Wright EK, Kamm MA, De Cruz P, Hamilton AL, Selvaraj F, Princen F, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Jakobovits SL, Florin TH, Gibson PR, Debinski H, Macrae FA, Samuel D, Kronborg I, Radford-Smith G, Gearry RB, Selby W, Bell SJ, Brown SJ, Connell WR.
    J Crohns Colitis; 2018 May 25; 12(6):653-661. PubMed ID: 29385469
    [Abstract] [Full Text] [Related]

  • 16. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR, Pierik M, Seinen ML, van Bodegraven AA, Gilissen LP, Bus P, Bakker JA, Masclee AA, Neef C, Engels LG, Hooymans PM.
    J Crohns Colitis; 2014 Feb 25; 8(2):120-8. PubMed ID: 23932783
    [Abstract] [Full Text] [Related]

  • 17. Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial.
    Mowat C, Arnott I, Cahill A, Smith M, Ahmad T, Subramanian S, Travis S, Morris J, Hamlin J, Dhar A, Nwokolo C, Edwards C, Creed T, Bloom S, Yousif M, Thomas L, Campbell S, Lewis SJ, Sebastian S, Sen S, Lal S, Hawkey C, Murray C, Cummings F, Goh J, Lindsay JO, Arebi N, Potts L, McKinley AJ, Thomson JM, Todd JA, Collie M, Dunlop MG, Mowat A, Gaya DR, Winter J, Naismith GD, Ennis H, Keerie C, Lewis S, Prescott RJ, Kennedy NA, Satsangi J, TOPPIC Study Group.
    Lancet Gastroenterol Hepatol; 2016 Dec 25; 1(4):273-282. PubMed ID: 28404197
    [Abstract] [Full Text] [Related]

  • 18. Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry.
    Cañete F, Mañosa M, Casanova MJ, González-Sueyro RC, Barrio J, Bermejo F, Nos P, Iglesias-Flores E, García-Planella E, Pérez-Calle JL, Vicente R, Vera M, Ramos L, Rivero M, De Francisco R, Montserrat A, Benítez O, Navarro P, Taxonera C, Hinojosa E, Márquez-Mosquera L, Navarro-Llavat M, Ramírez-de la Piscina P, Gomollón F, Rodríguez-Alonso L, Núñez-Alonso A, Fernández-Salazar L, Almela P, Ríos León R, De Castro L, Gisbert JP, Ricart E, Cabré E, Domènech E, ENEIDA registry by GETECCU.
    Inflamm Bowel Dis; 2019 Oct 18; 25(11):1862-1870. PubMed ID: 31006801
    [Abstract] [Full Text] [Related]

  • 19. Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn's Disease Recurrence.
    Ferrante M, Papamichael K, Duricova D, D'Haens G, Vermeire S, Archavlis E, Rutgeerts P, Bortlik M, Mantzaris G, Van Assche G, International Organization for Study of Inflammatory Bowel Diseases.
    J Crohns Colitis; 2015 Aug 18; 9(8):617-24. PubMed ID: 25926532
    [Abstract] [Full Text] [Related]

  • 20. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial.
    D'Haens GR, Vermeire S, Van Assche G, Noman M, Aerden I, Van Olmen G, Rutgeerts P.
    Gastroenterology; 2008 Oct 18; 135(4):1123-9. PubMed ID: 18727929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.